VivoSim Labs
VIVS
105 hedge funds and large institutions have $33.3M invested in VivoSim Labs in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 30 reducing their positions, and 24 closing their positions.
0.01% more ownership
Funds ownership: 0.11% → 0.12% (+0.01%)
10% less capital invested
Capital invested by funds: $37M → $33.3M (-$3.71M)
15% less funds holding
Funds holding: 123 → 105 (-18)
17% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 30
71% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 24
78% less call options, than puts
Call options by funds: $36K | Put options by funds: $166K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$6.51M |
| 2 |
Renaissance Technologies
New York
|
+$528K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$333K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$332K |
| 5 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$90.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$378K |
| 2 |
Bank of New York Mellon
New York
|
-$374K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$281K |
| 4 |
Millennium Management
New York
|
-$269K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$191K |
VIVS Hedge Fund Activity: Q1 2018 in Review
105 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2018, worth a combined $33.3M — down 10% from $37M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of VIVS and 7 opened new positions — a net loss of 17 holders — while 30 trimmed existing stakes and 25 added.
The largest buyer was ARK Investment Management, adding an estimated $6.51M. The largest seller was Citadel Advisors, exiting entirely with an estimated $378K sold.
- 105 institutional investors held VivoSim Labs (VIVS) as of Q1 2018, down from 123 in Q4 2017.
- Funds reported $33.3M of VivoSim Labs stock for Q1 2018, down 10% quarter-over-quarter.
- 7 funds opened new VivoSim Labs positions in Q1 2018 and 24 closed out, a net change of -17 holders.
- The largest VivoSim Labs buyer in Q1 2018 was ARK Investment Management, an estimated $6.51M added.
- The largest VivoSim Labs seller in Q1 2018 was Citadel Advisors, an estimated $378K sold.
Based on aggregated 13F filings for Q1 2018.